Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-α-induced shock

Molecular Medicine

Volumn 18, Issue 4, 2012, Pages 577-586

  Linkermann, Andreas ^a   Bräsen, Jan H ^a   de Zen, Federica ^a   Weinlich, Ricardo ^b   Schwendener, Reto A ^c   Green, Douglas R ^b   Kunzendorf, Ulrich ^a   Krautwald, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CERULETIDE; HYBRID PROTEIN; NECROSTATIN 1; PROTEIN; PROTEIN INHIBITOR; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 3; TAT CRMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL STRAIN HT29; CELL STRAIN L 929; CELL SURVIVAL; ENZYME INHIBITION; FEMALE; GENETIC DISORDER; GRANULOCYTE; HUMAN; HUMAN CELL; KNOCKOUT GENE; LEUKEMIA CELL LINE; MACROPHAGE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NECROPTOSIS; NONHUMAN; PANCREAS INJURY; PANCREATITIS; PRIORITY JOURNAL; PROTECTION; SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE INHIBITORS; CASPASES; CELL LINE, TUMOR; FEMALE; GENE PRODUCTS, TAT; HUMANS; IMIDAZOLES; INDOLES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; NECROSIS; PANCREATITIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; SERPINS; SHOCK; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 84862175306     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00423     Document Type: Article

References (51)

1. Holler N, et al. (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1:489-495.
2. Matsumura H, et al. (2000) Necrotic death pathway in Fas receptor signaling. J. Cell Biol. 151:1247-1256.
3. Schulze-Osthoff K, Krammer PH, Droge W. (1994) Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13:4587-4596.
4. Vercammen D, et al. (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187:1477-1485.
5. Hotchkiss RS, Nicholson DW. (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6:813-822.
6. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. (2009) Cell death. N. Engl. J. Med. 361:1570-1583.
7. Gerlach B, et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 471:591-596.
8. Haas TL, et al. (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell. 36:831-844.
9. Krammer PH, Arnold R, Lavrik IN. (2007) Life and death in peripheral T cells. Nat. Rev. Immunol. 7:532-542.
10. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11:700-714.
11. Challa S, Chan FK. (2010) Going up in flames: necrotic cell injury and inflammatory diseases. Cell Mol. Life Sci.
12. Christofferson DE, Yuan J. (2010) Necroptosis as an alternative form of programmed cell death. Curr. Opin. Cell Biol. 22:263-268.
13. Declercq W, Vanden Berghe T, Vandenabeele P. (2009) RIP kinases at the crossroads of cell death and survival. Cell. 138:229-232.
14. Oberst A, et al. (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature. 471:363-367.
15. Galluzzi L, et al. (2011) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death. Differ. 19:107-120.
16. He S, et al. (2009) Receptor interacting protein ki-nase-3 determines cellular necrotic response to TNF-alpha. Cell 137:1100-1111.
17. Vandenabeele P, Vanden Berghe T, Festjens N. (2006) Caspase inhibitors promote alternative cell death pathways. Sci. STKE. 2006:e44.
18. Cho YS, et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 137:1112-23.
19. Ch'en IL, et al. (2008) Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc. Natl. Acad. Sci. U.S.A 105:17463-17468.
20. Trichonas G, et al. (2010) Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 107:21695-21700.
21. Northington FJ, et al. (2011) Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J. Cereb. Blood Flow Metab. 31:178-189.
22. Smith CC, et al. (2007) Necrostatin: a potentially novel cardioprotective agent? Cardiovasc. Drugs Ther. 21:227-233.
23. Linkermann A et al. (2012) Rip1 (receptor-interacting protein kinase 1) mediates necropto-sis and contributes to renal ischemia/reperfusion injury. Kidney Int. 81:751-761.
24. Kaiser WJ, et al. (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature. 471:368-372.
25. Zhang DW, et al. (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 325:332-336.
26. Biton S, Ashkenazi A. (2011) NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell. 145:92-103.
27. Degterev A, et al. (2008) Identification of RIP1 ki-nase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4:313-321.
28. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P. (2003) Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4:387-393.
29. Upton JW, Kaiser WJ, Mocarski ES. (2010) Virus inhibition of RIP3-dependent necrosis. Cell Host. Microbe 7:302-313.
30. Zhang DW, et al. (2011). Multiple death pathways in TNF-treated fibroblasts. Cell Res. 2011. 21:368-371.
31. Garcia-Calvo M, et al. (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273:32608-32613.
32. Krautwald S, et al. (2010) Effective blockage of both the extrinsic and intrinsic pathways of apo-ptosis in mice by TAT-crmA. J. Biol. Chem. 285:19997-20005.
33. Christofferson DE, Yuan J. (2010) Cyclophilin A release as a biomarker of necrotic cell death. Cell Death. Differ. 17:1942-1943.
34. Newton K, Sun X, Dixit VM. (2004). Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell Biol. 24:1464-1469.
35. Chen Y, et al. (2010). Dual autonomous mitochon-drial cell death pathways are activated by Nix/ BNip3L and induce cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 107:9035-9042.
36. Sawai H, Domae N. (2011) Discrimination between primary necrosis and apoptosis by necro-statin-1 in Annexin V-positive/propidium iodide-negative cells. Biochem. Biophys. Res. Commun. 411:569-573.
37. Wu YT, et al. (2011) zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ. 18:26-37.
38. Linkermann A, et al. (2011) Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int. 79:169-178.
39. Callus BA, Vaux DL. (2007) Caspase inhibitors: viral, cellular and chemical. Cell Death.Differ. 14:73-78.
40. Gubser C, et al. (2007) A new inhibitor of apopto-sis from vaccinia virus and eukaryotes. PLoS. Pathog. 3:e17.
41. Zhou Q, et al. (1997) Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272:7797-7800.
42. Krautwald S, Ziegler E, Tiede K, Pust R, Kunzendorf U. (2004) Transduction of the TAT-FLIP fusion protein results in transient resistance to Fas-induced apoptosis in vivo. J. Biol. Chem. 279:44005-44011.
43. Devalaraja-Narashimha K, Diener AM, Padanilam BJ. (2009) Cyclophilin D gene ablation protects mice from ischemic renal injury. Am. J. Physiol. Renal Physiol. 297:F749-F759.
44. Cinel I, Opal SM. (2009) Molecular biology of inflammation and sepsis: a primer. Crit. Care Med. 37:291-304.
45. Hotchkiss RS, et al. (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. U.S.A. 96:14541-14546.
46. Quan LT, Caputo A, Bleackley RC, Pickup DJ, Salvesen GS. (1995) Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270:10377-10379.
47. Duprez L, et al. (2011) RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity. 35:908-918.
48. Degterev A, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1:112-119.
49. Jagtap PG, et al. (2007) Structure-activity relationship study of tricyclic necroptosis inhibitors. J. Med. Chem. 50:1886-1895.
50. Temkin V, Huang Q, Liu H, Osada H, Pope RM. (2006) Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol. Cell Biol. 26:2215-2225.
51. Kung G, Konstantinidis K, Kitsis RN. (2011) Programmed necrosis, not apoptosis, in the heart. Circ. Res. 108:1017-1036.